Asare-Werehene, M., Communal, L., Carmona, E., Le, T., Provencher, D., Mes-Masson, A., & Tsang, B. K. (2019). Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer. Scientific reports, 9(1), 13924-9. https://doi.org/10.1038/s41598-019-50436-1
Chicago Style (17th ed.) CitationAsare-Werehene, Meshach, Laudine Communal, Euridice Carmona, Tien Le, Diane Provencher, Anne-Marie Mes-Masson, and Benjamin K. Tsang. "Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer." Scientific Reports 9, no. 1 (2019): 13924-9. https://doi.org/10.1038/s41598-019-50436-1.
MLA (9th ed.) CitationAsare-Werehene, Meshach, et al. "Pre-operative Circulating Plasma Gelsolin Predicts Residual Disease and Detects Early Stage Ovarian Cancer." Scientific Reports, vol. 9, no. 1, 2019, pp. 13924-9, https://doi.org/10.1038/s41598-019-50436-1.